What was Tetratherix Limited’s price range in the past 12 months?
Tetratherix Limited lowest share price was AU$3.09 and its highest was AU$8.08 in the past 12 months.
What is Tetratherix Limited’s market cap?
Tetratherix Limited’s market cap is AU$342.42M.
When is Tetratherix Limited’s upcoming earnings report date?
Tetratherix Limited’s next earnings report is estimated for Mar 01, 2027 (not yet confirmed), which is in 105 days.
How were Tetratherix Limited’s earnings last quarter?
Tetratherix Limited released its earnings results on Aug 19, 2026. The company reported -AU$0.092 earnings per share for the quarter, missing the consensus estimate of -AU$0.081 by -AU$0.011.
Is Tetratherix Limited overvalued?
According to Wall Street analysts Tetratherix Limited’s price is currently Undervalued.
Does Tetratherix Limited pay dividends?
Tetratherix Limited does not currently pay dividends.
What is Tetratherix Limited’s EPS estimate?
Tetratherix Limited’s EPS estimate is -0.05.
How many shares outstanding does Tetratherix Limited have?
Tetratherix Limited has 53,503,113 shares outstanding.
What happened to Tetratherix Limited’s price movement after its last earnings report?
Tetratherix Limited reported an EPS of -AU$0.092 in its last earnings report, missing expectations of -AU$0.081. Following the earnings report the stock price went up 4.274%.
Which hedge fund is a major shareholder of Tetratherix Limited?
Currently, no hedge funds are holding shares in AU:TTX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Established in 2015 and headquartered in Alexandria, Australia, Tetratherix Ltd. operates in the biomaterials and regenerative medicine sectors across both domestic and international markets. The company develops and supplies products using its proprietary Tetramatrix platform technology, with a focus on applications including bone regeneration, tissue spacing, and advanced tissue healing.